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INTRODUCTION
Healthcare innovation has shaped the evolution of plastic sur-
gery in the last century. Perhaps the most historic demonstra-
tion of such was the pioneering work of Sirs Harold Gillies and 
Archibald McIndoe in the World Wars of 1914 and 1939 [1,2]. 
Since then, both invention and implementation of new technol-
ogies have continued to facilitate advances in patient outcomes 
and opportunities in plastic surgery. 
Outside of the healthcare literature, the study of the process of 
innovation (i.e., diffusion of innovation) is a mature field origi-
nating from the observations of social scientists in the mid-twen-
tieth century [3,4]. Patents and publications are well-document-
ed measures of innovation and exist in vast numbers detailing 
technological advances in surgery. Although articles exist in the 
healthcare literature relating to the diffusion of innovation, many 
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focus on healthcare processes with few offering an objective or 
quantitative view of the diffusion of technological innovation [5]. 
Key plastic surgical innovations, in the context of both research 
and clinical medicine, listed in the literature include microsur-
gery, breast surgery, liposuction, tissue engineering, transplanta-
tion, and laser technology [6,7]. These suggestions were made 
on the basis of significant professional experience, but a distinct 
lack of evidence. Recent work has demonstrated the utility of 
publically available patent and publication data to quantify in-
novation within surgery and proposes a novel methodology for 
assessing areas of technological innovation [8-10]. 
Such systematic approaches to horizon scanning for new evi-
dence of innovation poses significant opportunities and implica-
tions within research-funding bodies and investors alike. Current 
strategies for directing the nature of calls for proposals, as well as 
choosing those that are supported, might be more reliably guid-
ed by more robust technology trend analyses. Furthermore, re-
viewing these historical data might better inform academic pro-
grammes when appraising and advancing research angles.
The objectives of this paper are: first, to identify and character-
ise the most prevalent areas of innovation in plastic surgery us-
ing patent and publication data; and second, to evaluate key ar-
eas of innovation outlined by experts in the literature.
METHODS
Patent and publication data retrieval
Patents from over 90 countries and publications for plastic sur-
gery between 1960 and 2010 were retrieved using the proprie-
tary software PatentInspiration (Aulive, Ypres, Belgium) and Pub-
Med (National Library of Medicine, Bethesda, MD, USA). The 
Boolean search strategy (“plastic surgery” OR “plastic surgeon” 
OR “plastic surgical”) was used, limiting the results to single 
members of patent families in order to prevent duplication. Data 
for patent and publication activity were normalised using an in-
novation index as described by Hughes-Hallett et al. [8]. The 
innovation index is calculated by dividing the number of publi-
cations or patents in a given year by the total patent and publica-
tion counts from 2010 (‘present day’). This has the effect of 
highlighting change in activity beyond that caused by natural 
growth in industry and the population. 
Top performing patent codes
Every patent filed is classified using one or more standardised 
hierarchical codes, e.g., ‘A61F2/12’ for Mammary prostheses 
and implants. The 50 most prevalent patent codes associated 
with the technologies retrieved from the database search were 
identified and grouped under subheadings chosen by the au-
thors. Assignment of codes into technology areas was conduct-
ed independently by 2 authors (R.M.K. and H.J.M.), with any 
disagreement being resolved by a third (A.H.H.). Patents related 
to pharmaceutical products were omitted. This process was re-
peated each decade to explore change over time. 
The activity of the top performing technology areas was inves-
tigated further through specific searches of patents and publica-
tions. Search terms were built and modified to minimise the ap-
pearance of unwanted results on a case-by-case basis. For exam-
ple, in cases where search terms might be considered generic, 
such as ‘device’, patent searches were limited to results in which 
the term was present in the title or abstract. Normalised data 
After data normalisation with respect to total publications or patents filed (all fields), the publication activity appears to be steady, whereas pat-
ent activity is exhibiting an exponential rise. 
Fig. 1. Publication and patent activity in plastic surgery
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were plotted graphically to facilitate the assessment of growth 
patterns. To account for smaller datasets related to specific tech-
nologies, moving averages were employed in order to ease inter-
pretation.
Expert-derived technologies
A further series of searches was conducted to investigate expert-
derived specific areas of interest highlighted in 2 publications 
[6,7], which were vulnerable to absorption by generic technolo-
gy subheadings in the initial search strategy.
Statistical analysis
Evidence suggests that a high correlation between patents and 
publications during periods of growth is indicative of substantial 
innovation [11]; therefore, correlation coefficients were calcu-
lated. In the case of a monotonic relationship, Pearson’s or Spear-
man’s rank was used for linear or non-linear associations, respec-
tively. The coefficient of determination (R2) was used to quanti-
fy and compare the fit of data to linear and exponential trend 
lines. Statistical analysis was performed using the IBM SPSS ver. 
19.0 (IBM Co., Armonk, NY, USA).
RESULTS
In plastic surgery between 1960 and 2010, 4,651 patents and 
43,118 publications were retrieved. After normalisation, the pub-
Code Frequency Code description
A61L27/227
A61L27/56
A61L27/24
A61L27/18
A61L27/54
A61L2430/02
A61L27/34
A61L27/50
A61L27/52
A61F2310/00365
A61L27/3608
A61F2210/0004
A61L27/58
A61F2/28
A61L27/3683
A61L27/16
A61F2002/30062
A61L27/12
135
125
113
111
108
105
104
95
89
88
87
83
77
77
74
68
67
67
1,676
Reconstructive prostheses
Polypeptide macromolecular materials for prostheses or coating prostheses
Porous materials for prostheses or coating prostheses
Collagen materials for prostheses or coating prostheses
Macromolecular materials (non C-C unsat bonds) for prostheses or coating
Biologically active materials for prostheses or coating
Materials or treatment for tissue regeneration - bones and weight-bearing implants
Macromolecular materials for coating prostheses
Material characterised by their function or physical properties for prostheses or coating prostheses
Hydrogel materials for prostheses or coating prostheses
Proteins for prostheses
Bony prostheses
Bioabsorbable materials for prostheses
Partially resorbable materials for prostheses or coating prostheses
Bony implants or prostheses
Pre-implantation treated prostheses
Macromolecular materials (involving C-C unsat bonds) for prostheses or coating
Bioabsorbable materials for joint prostheses
Phosphorus-containing materials (e.g. apatite) for prostheses or coating prostheses
A61F2/12
A61F2/0059
198
106
304
Implants
Mammary prostheses and implants
Cosmetic or alloplastic implants
A61B2018/00452
A61B17/06166
A61B2017/00792
A61B19/24
98
79
75
71
323
Instruments
Surgical instruments for the skin
Sutures
Instruments for plastic surgery
Devices for expanding tissue
A61Q19/08
A61Q19/00
A61K9/0024
A61B18/203
167
160
102
82
511
Non-invasive
Anti-ageing preparations for the skin
Preparations for care of the skin
Solid, semi-solid or solidifying implants (injectables)
Applying laser energy to the outside of the body
A61L27/60
A61L27/3804
80
70
149
Tissue engineering
Materials used in artificial skin
Transplanted living cells
G06Q50/22 77
Miscellaneous
Patient record management
Table 1. Hierarchy of top 50 performing patent codes in plastic surgery between 1960 and 2010 (omitting pharmaceutical 
products)
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lication activity appeared to be steady, whereas patent activity 
exhibited an exponential rise (R2 exponential = 0.85) (Fig. 1).
Between 1960 and 2010, the top performing technology groups 
were reconstructive prostheses, non-invasive practices, surgical 
instruments, implants, and tissue engineering (Table 1).
Technologies related to surgical instruments were the most ac-
tive in terms of patent filing in the 1980’s. In the last two decades, 
patents related to reconstructive prostheses have become the 
most prevalent, with instruments and non-invasive techniques 
comprising the majority of the remaining technologies (Table 
2). Patents related to pharmaceutical products were omitted 
(1980’s, 8; 1990’s, 16; 2000’s, 17; 1960–2010, 19). 
Of the top performing technology areas (Table 3), instruments, 
non-invasive technologies and tissue engineering all have strong 
correlations between patent and publication activity (range Spear-
man’s rank, 0.678–0.893; P < 0.001). Implants, instruments and 
non-invasive technologies all appear to be undergoing growth, 
whilst reconstructive prostheses and tissue engineering have 
shown convincing plateaus. Of the growing technologies, instru-
ments and non-invasive technologies both show greater concor-
dance with exponential lines of best fit (average exponential vs. 
linear R2 = 0.8 vs. 0.7), whilst implants rise in a more linear fash-
ion (R2 = 0.6 vs. 0.7) (Fig. 2).
Microsurgery (within plastic surgery) accounted for 156 pat-
ents, following a sigmoidal growth curve plateauing in 2000. 
Breast surgery (109 patents) appeared to exhibit potentially two 
distinct growth phases—first in the 1980’s and again in the late 
2000’s. Liposuction (34) underwent rapid growth almost im-
mediately on conception in the late 1980’s, which was unsus-
tainable. Tissue engineering (403) and laser technologies (104) 
both exhibited sigmoidal growth curves with plateaus in the 
mid- and early 2000’s, respectively. Patents related to transplan-
tation (649) display a dramatic exponential growth phase around 
the year 2000, which is only very recently showing signs of ces-
sation. Of the growing technologies, transplantation was strong-
ly exponential (exponential vs. linear R2 = 0.7 vs. 0.3), whereas 
breast surgery was mostly exponential (R2 = 0.5 vs. 0.4) in its 
growth trend. The correlations between patents and publica-
tions were all statistically significant, with all apart from breast 
being strong (R > 0.7) (Fig. 3).
DISCUSSION
A novel innovation metric was applied to the field of plastic sur-
gery showing exponential growth in patents over the last 50 years, 
with a relatively fixed related publication output. This is an ex-
pected finding, considering that healthcare patents are outper-
forming patents in general (the latter of which were used for nor-
malisation). The top performing patent codes, and therefore ar-
eas of innovation, were identified as reconstructive prostheses, 
tissue engineering, implants, instruments, and non-invasive tech-
niques, of which the latter 3 are currently in growth. Expert-de-
rived innovation areas were also evaluated, highlighting the dif-
ferences (and similarities) between different technologies with 
Table 3. Search strategies
Technology Search strategy
Top performing 
   Reconstructive prostheses
   Implants
   Instruments
   Non-invasive
   Tissue engineering
(Prosthetic or prosthesis or prostheses) and (bone or joint) and (“plastic surgery” or “plastic surgeon” or “plastic surgical”)
(Implant or prosthetic or prosthesis or prostheses) not (bone or joint) and (“plastic surgery” or “plastic surgeon” or “plastic surgical”)
(Instrument or tool or device)φ and (“plastic surgery” or “plastic surgeon” or plastic surgical”)
(Laser or injectable or thermal)φ and (“plastic surgery” or “plastic surgeon” or “plastic surgical”)
(“Tissue engineering”) and (“plastic surgery” or “plastic surgeon” or “plastic surgical”)
Expert-derived
   Microsurgery
   Breast surgery
   Liposuction
   Transplant
   Tissue engineering
   Laser
(Microsurgery or microsurgical) and (“plastic surgery” or “plastic surgeon” or “plastic surgical”)
Breastφ and (“plastic surgery” or “plastic surgeon” or “plastic surgical”)
(Liposuction or lipoplasty or liposculpture or lipectomy)φ and (“plastic surgery” or “plastic surgeon” or “plastic surgical”)
(Allotransplant or allograft) and (“plastic surgery” or “plastic surgeon” or “plastic surgical”)
“Tissue engineering” and (“plastic surgery” or “plastic surgeon” or “plastic surgical”)
Laserφ and (“plastic surgery” or “plastic surgeon” or “plastic surgical”)
  φPatent search restricted to title or abstract. 
Table 2.  Number and distribution of patents over time 
Variable 1980’s 1990’s 2000’s 1960-2010
Patent code frequency (%)
   Reconstructive prostheses
   Implants
   Instruments
   Non-invasive
   Tissue engineering
163 (28)
102 (18)
229 (40)
36 (6)
22 (4)
775 (61)
100 (8)
89 (7)
192 (15)
115 (9)
687 (38)
112 (6)
421 (24)
366 (20)
90 (0.5)
1,676 (55)
304 (10)
323 (11)
511 (17)
149 (5)
Total patents (including  
   miscellaneous)
575 1,271 1,788 3,040
Separate patent searches were conducted for each time period. Patent numbers 
in the top 5 technology clusters between 1980–2010 surpass those in 1960–
2010 as there were more top ranking pharmaceutical patent codes and therefore 
more patents omitted. Each column (time period) must therefore be considered 
independently.
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This figure shows the normalised publication and patent trends for the 5 top performing (i.e., most prevalent) overarching patent codes. The trends 
were assessed statistically for correlation between publications and patents, current growth, and exponential growth (as described in the text).
Fig. 2. Top performing patent codes in plastic surgery
140
120
100
80
60
40
20
0
N
o.
 o
f 
pu
bl
ic
at
io
ns
250
200
150
100
50
0
N
o.
 o
f 
pa
te
nt
s
1960 1970 1980 1990 2000 2010
Reconstructive prostheses
Publications
Patents
300
250
200
150
100
50
0
N
o.
 o
f 
pu
bl
ic
at
io
ns
70
60
50
40
30
20
10
0
N
o.
 o
f 
pa
te
nt
s
1960 1970 1980 1990 2000 2010
Implants
1,200
1,000
800
600
400
200
0
N
o.
 o
f 
pu
bl
ic
at
io
ns
160
140
120
100
80
60
40
20
0
N
o.
 o
f 
pa
te
nt
s
1960 1970 1980 1990 2000 2010
Instruments
200
180
160
140
120
100
80
60
40
20
0
N
o.
 o
f 
pu
bl
ic
at
io
ns
50
45
40
35
30
25
20
15
10
5
0
N
o.
 o
f 
pa
te
nt
s
1960 1970 1980 1990 2000 2010
Non-invasive
80
70
60
50
40
30
20
10
0
N
o.
 o
f 
pu
bl
ic
at
io
ns
90
80
70
60
50
40
30
20
10
0
N
o.
 o
f 
pa
te
nt
s
1960 1970 1980 1990 2000 2010
Tissue engineering
respect to time of conception, growth patterns, and the current 
state of flux.
The Diffusion of Innovation theory described by Rogers pro-
poses that the technology adoption curve is sigmoidal, with a 
period of incubation prior to widespread adoption, followed by 
technological refinement [3]. The data displayed in this work 
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This figure compares different areas of innovation as selected by senior plastic surgeons. The normalised data have also been adjusted relative to 
each area, that is, yearly values divided by technology-specific 2010 values, and therefore trends rather than quantitative data may be compared. 
The publication and patent trends correlated strongly, and it is apparent that some technologies are currently undergoing growth whilst others 
have plateaued or are in a static or slump phase.
Fig. 3. Publication and patent activity in expert-derived technologies
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facilitates guided speculation with regard to forecasting future 
areas of growth by establishing the current phase of innovation 
in a particular technology. Technologies currently experiencing 
growth include surgical instruments, implants, non-invasive 
techniques, transplantation, and breast surgery. Of these tech-
nologies, transplantation is visually and statistically the most ex-
ponential, with a concurrent boom in associated publication ac-
tivity. This is in keeping with the current interest in vascularised 
composite allotransplantation, both from expanding case series 
(including the first hand transplant in the UK in 2013) [12,13] 
and novel strategies for inducing immune tolerance [14,15] that 
address the ethical constraints associated with long-term immu-
nosuppression [16].
The correlation between publications and patents of the ma-
jority of the technology groups were strong, suggesting substan-
tial innovation. However, patents and publications for recon-
structive prostheses and implants were poorly correlated. Publi-
cation activity in these areas emerges rapidly in the 1960’s be-
fore plateauing, whereas patents activity rises later on with little 
impact on publication activity. A poor correlation between pub-
lications and patents has previously been explained by periods 
of technology refinement, where mature technologies are incre-
mentally refined by industry to maintain market share, rather 
than to modify clinical practice [11]. 
The majority of innovations listed by senior plastic surgeons 
were reassuringly represented in the top performing patent codes. 
Overarching technology areas are likely to envelop niche pat-
ents, such as liposuction and negative pressure dressings falling 
under instruments, for example. Simple and useful technologies 
such as liposuction exhibit rapid uptake with a befitting expo-
nential rise, before falling away as the limited number of plausi-
ble amendments or advances are exhausted.
Microsurgery is undoubtedly one of the most disruptive inno-
vations in plastic surgery [17]. After Jacobson and Suarez achiev-
ed the first experimental microvascular anastomosis using an 
operating microscope in 1960 [18], a prolonged incubation phase 
saw various microsurgical cases documented, such as the first 
arm replant in 1964 [19]. It was only after the assembly of the 
International Society of Reconstructive Microsurgery in 1972 
that the technique began to be more widely adopted, with a sub-
sequent surge in patent activity. 
The patent activity of half the technologies explored has pla-
teaued. It is possible that other emerging innovations in plastic 
surgery have been missed. It is also likely that innovation is oc-
curring in other surgical specialties, to be adopted by plastic sur-
geons in due course. Hughes-Hallett listed the key areas of inno-
vation in surgery as minimally invasive surgery, robotic surgery, 
surgical staplers, and image guidance, with robotics and image 
guidance very much in the exponential phase of growth [8]. Use 
of robotic platforms for microvascular anastomosis or neuror-
rhaphy [20], imaging for locating perforating blood vessels [21], 
and planning surgical reconstruction [22] are beginning to be 
described in the plastic surgical literature. 
Amongst other interesting findings, patient record manage-
ment was the top performing plastic surgery patent in the 2000’s 
(aside from skin preparations). Similarly, this decade sees the 
emergence of the patent code for software for market research 
and analysis. This suggests that the focus of innovation is ex-
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panding to address more holistic aspects of the healthcare pro-
cess, including managing and extracting information from so-
called ‘big data’ to optimise care pathways whilst maintaining a 
robust healthcare business model.
Although the methodology used provides new insight into in-
novation in plastic surgery, it is not without limitations. As with 
systematic reviews, building search terms is an inherent source 
of bias. To minimise bias, search terms were kept concise, avoid-
ing listing specific technologies to add to or limit the search where 
possible. Also, the same search terms were used for patents and 
publications, regardless of differences in article architecture. Ad-
ditionally, the results generated from nonspecific patent search 
terms such as ‘device’ were restricted to those found in the title 
or abstract and not the description, which can often include a 
broader discussion of technology components not central to the 
innovation in focus in the patent.
Reconstructive prostheses comprise a large industry, which 
spans multiple specialties. Whilst such technology may be more 
typically associated with orthopaedics, the wide applicability 
and the format of the patent applications result in it being a ma-
jor feature in this study. Plastic surgery is unique in that the spe-
cialty is not confined to a single organ or organ system, which 
makes defining a search strategy more challenging. The study 
methodology was more likely to be overly inclusive rather than 
incomplete, as any technology that may be encountered by a 
plastic surgeon is likely to be listed in the patent application.
Furthermore, patent records are such that any patent may fall 
under more than 1 code, potentially leading to over-representa-
tion of a particular patent when assessing the top performing 
patent areas. It is conceivable that this phenomenon is skewed 
towards certain technology areas, for example a new multi-mod-
ular hip prosthesis with a smart coating may result in 5 or more 
‘hits’ on various prosthesis-related patent codes (Table 1), where-
as a breast implant has fewer possibilities. Conducting patent 
searches using expert-derived technologies in addition to those 
representing top performing patent codes ensures areas of inter-
est are not disregarded. 
The application of a novel metric for evaluating innovation in 
plastic surgery generated a natural history of technologies fun-
damental to the evolution of the specialty. This methodology 
has revealed which technologies are currently undergoing growth, 
providing unique insight into the expected landscape of clinical 
and academic plastic surgery in the decades to come. Future 
work may look to advance the methodology in order to detect 
the features of emerging technology groups that may be able to 
predict uptake and ultimately success. Learning from historical 
trends in patents and publications, along with additional supple-
mentary metrics, might allow the most promising ‘seedlings’ to 
be selected and nurtured through direct resource allocation. This 
method has the potential to fast track the development and trans-
lation of new disruptive technologies into the healthcare domain.
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